Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial
Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single‐blinded clinical trial. Methods In all, 20 subjects with cervical me...
Saved in:
Published in | Head & neck Vol. 33; no. 7; pp. 935 - 940 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.07.2011
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single‐blinded clinical trial.
Methods
In all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work‐up.
Results
PET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan.
Conclusions
An unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment. © 2010 Wiley Periodicals, Inc. Head Neck, 2011 |
---|---|
AbstractList | Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single-blinded clinical trial.
In all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work-up.
PET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan.
An unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment. Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single‐blinded clinical trial. Methods In all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work‐up. Results PET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan. Conclusions An unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment. © 2010 Wiley Periodicals, Inc. Head Neck, 2011 Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single-blinded clinical trial.BACKGROUNDMetastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single-blinded clinical trial.In all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work-up.METHODSIn all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work-up.PET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan.RESULTSPET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan.An unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment.CONCLUSIONSAn unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment. |
Author | Matthews, T. Wayne Molnar, Christine P. Kloiber, Reinhard Rudmik, Luke Dort, Joseph C. Bosch, J. Douglas Lau, Harold Y. |
Author_xml | – sequence: 1 givenname: Luke surname: Rudmik fullname: Rudmik, Luke organization: Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, Canada – sequence: 2 givenname: Harold Y. surname: Lau fullname: Lau, Harold Y. organization: Division of Radiation Oncology, Department of Oncology, University of Calgary, Calgary, Canada – sequence: 3 givenname: T. Wayne surname: Matthews fullname: Matthews, T. Wayne organization: Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, Canada – sequence: 4 givenname: J. Douglas surname: Bosch fullname: Bosch, J. Douglas organization: Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, Canada – sequence: 5 givenname: Reinhard surname: Kloiber fullname: Kloiber, Reinhard organization: Division of Nuclear Medicine, Department of Radiology, University of Calgary, Calgary, Canada – sequence: 6 givenname: Christine P. surname: Molnar fullname: Molnar, Christine P. organization: Division of Nuclear Medicine, Department of Radiology, University of Calgary, Calgary, Canada – sequence: 7 givenname: Joseph C. surname: Dort fullname: Dort, Joseph C. email: jdort@ucalgary.ca organization: Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, Canada |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24280686$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21674668$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kd9u0zAUxiM0xP7ABS-AfIMQF1nt2HEc7qbSdkhjIChwaZ04jmrqOFvsrPQZ9tJz1xQkBPKFj-Tfd46_850mR65zOkleEnxOMM4mK12fZyTn_ElyQnBZpJiy4mhXM5pSXLDj5NT7nxhjyln2LDnOCC8Y5-IkuZ9a44wCi4ZgrAlb1DXo82w5mS6RcSisNNJ3YAcIpnO7t5WGGoGrkdNqjfztAG03eKS0tUhBr4zrWkAbE1aRQoNbu27j0E1vWui379BFLDt_o1Uwdxqpw_DQG7DPk6cNWK9fjPdZ8m0-W04v06tPiw_Ti6tU0TLjaVPppqDAag4Kc8aoZqrkeZUVRSm4wCCAVIBBCUxYpeNhSjekVlDhMq8EPUve7PvGr9wO2gfZGr8zAE5HL1IUGaGYijySr0ZyqFpdy9GGPOwvAq9HAHz00fTglPF_OJYJzAWP3GTPqeje97qRyoTHnYYejJUEy12SMiYpH5OMird_KQ5N_8WO3TfG6u3_QXk5e39QpHuF8UH_-q2Afi15QYtc_rheyI-L-fzrNfsiv9MHRO29aQ |
CitedBy_id | crossref_primary_10_1002_cam4_1933 crossref_primary_10_4274_nts_galenos_2024_43153 crossref_primary_10_1016_j_rcl_2013_05_002 crossref_primary_10_1007_s00405_014_2980_z crossref_primary_10_1002_lary_28200 crossref_primary_10_1007_s00761_012_2318_7 crossref_primary_10_1007_s00761_012_2315_x crossref_primary_10_1002_hed_23830 crossref_primary_10_1097_MNM_0000000000001365 crossref_primary_10_1016_j_yoto_2011_10_003 crossref_primary_10_1007_s00259_015_3294_0 crossref_primary_10_1016_j_hoc_2021_05_004 crossref_primary_10_1016_j_jfma_2022_07_012 crossref_primary_10_1016_j_medcli_2012_04_033 crossref_primary_10_1002_hed_21898 crossref_primary_10_1056_NEJMra1303917 crossref_primary_10_11124_JBISRIR_2017_003476 crossref_primary_10_1002_lary_27625 crossref_primary_10_1016_j_otc_2013_04_011 crossref_primary_10_1111_ecc_13459 crossref_primary_10_1016_j_ijrobp_2017_02_217 crossref_primary_10_1177_0194599820933204 crossref_primary_10_1634_theoncologist_2015_0364 crossref_primary_10_1002_lary_27268 crossref_primary_10_1002_lary_23942 crossref_primary_10_1016_j_cpet_2014_09_006 crossref_primary_10_1007_s00259_021_05336_w crossref_primary_10_1200_JCO_20_00275 crossref_primary_10_1007_s00259_014_2972_7 crossref_primary_10_2214_AJR_14_12828 crossref_primary_10_1002_hed_25026 crossref_primary_10_1016_j_coms_2019_07_007 crossref_primary_10_1016_j_ctrv_2015_05_010 crossref_primary_10_3390_surgeries3030022 crossref_primary_10_4329_wjr_v6_i6_238 crossref_primary_10_1053_j_sult_2017_05_008 crossref_primary_10_1186_s40463_017_0217_z crossref_primary_10_17650_2222_1468_2019_9_2_35_42 crossref_primary_10_1016_j_cpet_2012_06_002 crossref_primary_10_1016_j_oraloncology_2019_03_014 crossref_primary_10_1016_j_jaad_2016_01_045 crossref_primary_10_1016_j_cpet_2015_05_002 crossref_primary_10_1186_1479_5876_10_12 crossref_primary_10_4329_wjr_v6_i5_177 crossref_primary_10_1002_hed_23372 crossref_primary_10_1007_s00106_017_0355_7 crossref_primary_10_1016_j_oraloncology_2012_05_022 crossref_primary_10_1016_j_clon_2012_08_007 crossref_primary_10_1016_j_cpet_2019_08_010 crossref_primary_10_1002_lary_27131 crossref_primary_10_1016_j_coms_2012_01_003 crossref_primary_10_1016_j_cpet_2012_06_007 crossref_primary_10_1016_j_critrevonc_2016_10_009 crossref_primary_10_1186_s40001_022_00957_9 crossref_primary_10_1007_s00259_015_3217_0 crossref_primary_10_1007_s40336_021_00429_w crossref_primary_10_3904_kjm_2021_96_5_408 crossref_primary_10_4103_ijmpo_ijmpo_91_17 crossref_primary_10_1016_j_mric_2023_08_001 crossref_primary_10_1002_lary_25783 crossref_primary_10_1007_s00117_013_2548_8 crossref_primary_10_1007_s00405_014_3125_0 crossref_primary_10_1016_j_oraloncology_2024_107083 crossref_primary_10_1158_1078_0432_CCR_12_3030 crossref_primary_10_4103_jcrt_JCRT_1083_20 crossref_primary_10_1002_hed_23385 crossref_primary_10_1002_hed_25522 crossref_primary_10_1186_s40463_023_00623_y |
Cites_doi | 10.1067/mhn.2001.114309 10.1097/MNM.0b013e3280708edf 10.1177/1740774509102310 10.1155/2009/208725 10.1016/j.ctrv.2003.10.001 10.1097/00005537-199811000-00004 10.1002/cncr.20687 10.1016/j.oraloncology.2008.05.010 10.1016/S0197-2456(99)00017-3 10.6004/jnccn.2008.0080 10.1002/lary.20638 10.1002/(SICI)1097-0347(199812)20:8<739::AID-HED13>3.0.CO;2-0 10.1200/JCO.2008.17.8905 10.1002/1097-0142(19930901)72:5<1756::AID-CNCR2820720540>3.0.CO;2-5 10.1097/MLG.0b013e31805d017b 10.1002/cncr.22410 10.1002/hed.20734 10.1002/hed.20654 10.1016/S0167-8140(00)00172-9 |
ContentType | Journal Article |
Copyright | Copyright © 2010 Wiley Periodicals, Inc. 2015 INIST-CNRS |
Copyright_xml | – notice: Copyright © 2010 Wiley Periodicals, Inc. – notice: 2015 INIST-CNRS |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1002/hed.21566 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1097-0347 |
EndPage | 940 |
ExternalDocumentID | 21674668 24280686 10_1002_hed_21566 HED21566 ark_67375_WNG_MGFFSN4R_V |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Ohlson Research Initiative, Faculty of Medicine, University of Calgary – fundername: Calgary Surgical Education and Research Trust |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 36B 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADZMN ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBD EBS EJD EMB EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c3926-fbef73a4d6ac06443e4c965b27798680a8a1ba0ac8014bebeb4cef1dcab095b83 |
IEDL.DBID | DR2 |
ISSN | 1043-3074 1097-0347 |
IngestDate | Thu Jul 10 18:49:55 EDT 2025 Mon Jul 21 05:50:25 EDT 2025 Mon Jul 21 09:15:40 EDT 2025 Tue Jul 01 03:27:43 EDT 2025 Thu Apr 24 23:12:46 EDT 2025 Wed Jan 22 16:50:05 EST 2025 Wed Oct 30 09:53:12 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Radionuclide study head and neck imaging Evaluation Radiodiagnosis Stomatology unknown primary ENT Malignant tumor clinical utility PET/CT Head and neck Medical imagery ENT disease Head and neck cancer Head and neck squamous cell carcinoma Clinical trial Computerized axial tomography Positron emission tomography Cancer Emission tomography |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 Copyright © 2010 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3926-fbef73a4d6ac06443e4c965b27798680a8a1ba0ac8014bebeb4cef1dcab095b83 |
Notes | ark:/67375/WNG-MGFFSN4R-V Ohlson Research Initiative, Faculty of Medicine, University of Calgary istex:D1CDE97CCD998C6E417CA4B9D7D506ED429F1396 ArticleID:HED21566 Calgary Surgical Education and Research Trust ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21674668 |
PQID | 872130385 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_872130385 pubmed_primary_21674668 pascalfrancis_primary_24280686 crossref_citationtrail_10_1002_hed_21566 crossref_primary_10_1002_hed_21566 wiley_primary_10_1002_hed_21566_HED21566 istex_primary_ark_67375_WNG_MGFFSN4R_V |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2011 |
PublicationDateYYYYMMDD | 2011-07-01 |
PublicationDate_xml | – month: 07 year: 2011 text: July 2011 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
PublicationTitle | Head & neck |
PublicationTitleAlternate | Head Neck |
PublicationYear | 2011 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley |
References | Freidlin B, Korn EL. Stopping clinical trials early for benefit: impact on estimation. Clin Trials 2009; 6: 119-125. Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998; 20: 739-744. Fleming AJJr, Smith SPJr, Paul CM, et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007; 117: 1173-1179. Galer CE, Kies MS. Evaluation and management of the unknown primary carcinoma of the head and neck. J Natl Compr Canc Netw 2008; 6: 1068-1075. Wartski M, Le Stanc E, Gontier E, et al. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET/CT. Nucl Med Commun 2007; 28: 365-371. Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 2004; 101: 2641-2649. Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 2008; 30: 28-34. McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM. Occult tonsillar carcinoma in the unknown primary. Laryngoscope 1998; 108: 1605-1610. Roh JL, Kim JS, Lee JH, et al. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 2009; 45: 218-224. Freidlin B, Korn EL, George SL. Data monitoring committees and interim monitoring guidelines. Control Clin Trials 1999; 20: 395-407. Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 2004; 30: 153-164. Johansen J, Buus S, Loft A, et al. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 2008; 30: 471-478. Seve P, Billotey C, Broussolle C, Dumontet C, Mackey JR. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer 2007; 109: 292-299. Cianchetti M, Mancuso AA, Amdur RJ, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 2009; 119: 2348-2354. Al-Ibraheem A, Buck A, Krause BJ, Scheidhauer K, Schwaiger M. Clinical applications of FDG PET and PET/CT in head and neck cancer. J Oncol 2009; 208725: 1-13. Freidlin B, Korn EL. Monitoring for lack of benefit: a critical component of a randomized clinical trial. J Clin Oncol 2009; 27: 629-633. Jones AS, Cook JA, Phillips DE, Roland NR. Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer 1993; 72: 1756-1761. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000; 55: 121-129. Koch WM, Bhatti N, Williams MF, Eisele DW. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 2001; 124: 331-333. 2004; 101 2007; 28 2009; 45 2004; 30 2001; 124 2007; 117 1993; 72 2000; 55 1998; 108 1999; 20 2008; 6 2009; 6 2008; 30 2009; 119 2007; 109 1998; 20 2009; 27 2009; 208725 e_1_2_7_5_2 e_1_2_7_4_2 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_19_2 e_1_2_7_18_2 e_1_2_7_17_2 e_1_2_7_16_2 e_1_2_7_15_2 e_1_2_7_14_2 e_1_2_7_13_2 e_1_2_7_12_2 e_1_2_7_11_2 e_1_2_7_10_2 e_1_2_7_20_2 22638936 - Strahlenther Onkol. 2012 Jul;188(7):637-8 |
References_xml | – reference: Jones AS, Cook JA, Phillips DE, Roland NR. Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer 1993; 72: 1756-1761. – reference: Al-Ibraheem A, Buck A, Krause BJ, Scheidhauer K, Schwaiger M. Clinical applications of FDG PET and PET/CT in head and neck cancer. J Oncol 2009; 208725: 1-13. – reference: Wartski M, Le Stanc E, Gontier E, et al. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET/CT. Nucl Med Commun 2007; 28: 365-371. – reference: Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 2004; 101: 2641-2649. – reference: Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 2004; 30: 153-164. – reference: Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998; 20: 739-744. – reference: Freidlin B, Korn EL. Stopping clinical trials early for benefit: impact on estimation. Clin Trials 2009; 6: 119-125. – reference: Seve P, Billotey C, Broussolle C, Dumontet C, Mackey JR. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer 2007; 109: 292-299. – reference: Cianchetti M, Mancuso AA, Amdur RJ, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 2009; 119: 2348-2354. – reference: Roh JL, Kim JS, Lee JH, et al. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 2009; 45: 218-224. – reference: Koch WM, Bhatti N, Williams MF, Eisele DW. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 2001; 124: 331-333. – reference: Johansen J, Buus S, Loft A, et al. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 2008; 30: 471-478. – reference: Fleming AJJr, Smith SPJr, Paul CM, et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007; 117: 1173-1179. – reference: Galer CE, Kies MS. Evaluation and management of the unknown primary carcinoma of the head and neck. J Natl Compr Canc Netw 2008; 6: 1068-1075. – reference: Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 2008; 30: 28-34. – reference: Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000; 55: 121-129. – reference: McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM. Occult tonsillar carcinoma in the unknown primary. Laryngoscope 1998; 108: 1605-1610. – reference: Freidlin B, Korn EL, George SL. Data monitoring committees and interim monitoring guidelines. Control Clin Trials 1999; 20: 395-407. – reference: Freidlin B, Korn EL. Monitoring for lack of benefit: a critical component of a randomized clinical trial. J Clin Oncol 2009; 27: 629-633. – volume: 124 start-page: 331 year: 2001 end-page: 333 article-title: Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source publication-title: Otolaryngol Head Neck Surg – volume: 30 start-page: 28 year: 2008 end-page: 34 article-title: Management of the unknown primary carcinoma: long‐term follow‐up on a negative PET scan and negative panendoscopy publication-title: Head Neck – volume: 6 start-page: 1068 year: 2008 end-page: 1075 article-title: Evaluation and management of the unknown primary carcinoma of the head and neck publication-title: J Natl Compr Canc Netw – volume: 6 start-page: 119 year: 2009 end-page: 125 article-title: Stopping clinical trials early for benefit: impact on estimation publication-title: Clin Trials – volume: 108 start-page: 1605 year: 1998 end-page: 1610 article-title: Occult tonsillar carcinoma in the unknown primary publication-title: Laryngoscope – volume: 119 start-page: 2348 year: 2009 end-page: 2354 article-title: Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site publication-title: Laryngoscope – volume: 20 start-page: 739 year: 1998 end-page: 744 article-title: Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site publication-title: Head Neck – volume: 101 start-page: 2641 year: 2004 end-page: 2649 article-title: The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor publication-title: Cancer – volume: 55 start-page: 121 year: 2000 end-page: 129 article-title: Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology publication-title: Radiother Oncol – volume: 30 start-page: 153 year: 2004 end-page: 164 article-title: Cervical lymph node metastases of squamous cell carcinoma from an unknown primary publication-title: Cancer Treat Rev – volume: 27 start-page: 629 year: 2009 end-page: 633 article-title: Monitoring for lack of benefit: a critical component of a randomized clinical trial publication-title: J Clin Oncol – volume: 109 start-page: 292 year: 2007 end-page: 299 article-title: The role of 2‐deoxy‐2‐[F‐18]fluoro‐D‐glucose positron emission tomography in disseminated carcinoma of unknown primary site publication-title: Cancer – volume: 45 start-page: 218 year: 2009 end-page: 224 article-title: Utility of combined (18)F‐fluorodeoxyglucose‐positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors publication-title: Oral Oncol – volume: 72 start-page: 1756 year: 1993 end-page: 1761 article-title: Squamous carcinoma presenting as an enlarged cervical lymph node publication-title: Cancer – volume: 208725 start-page: 1 year: 2009 end-page: 13 article-title: Clinical applications of FDG PET and PET/CT in head and neck cancer publication-title: J Oncol – volume: 30 start-page: 471 year: 2008 end-page: 478 article-title: Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA‐13 study publication-title: Head Neck – volume: 20 start-page: 395 year: 1999 end-page: 407 article-title: Data monitoring committees and interim monitoring guidelines publication-title: Control Clin Trials – volume: 117 start-page: 1173 year: 2007 end-page: 1179 article-title: Impact of [18F]‐2‐fluorodeoxyglucose‐positron emission tomography/computed tomography on previously untreated head and neck cancer patients publication-title: Laryngoscope – volume: 28 start-page: 365 year: 2007 end-page: 371 article-title: In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG‐PET/CT publication-title: Nucl Med Commun – ident: e_1_2_7_19_2 doi: 10.1067/mhn.2001.114309 – ident: e_1_2_7_14_2 doi: 10.1097/MNM.0b013e3280708edf – ident: e_1_2_7_15_2 doi: 10.1177/1740774509102310 – ident: e_1_2_7_11_2 doi: 10.1155/2009/208725 – ident: e_1_2_7_4_2 doi: 10.1016/j.ctrv.2003.10.001 – ident: e_1_2_7_20_2 doi: 10.1097/00005537-199811000-00004 – ident: e_1_2_7_12_2 doi: 10.1002/cncr.20687 – ident: e_1_2_7_17_2 doi: 10.1016/j.oraloncology.2008.05.010 – ident: e_1_2_7_18_2 doi: 10.1016/S0197-2456(99)00017-3 – ident: e_1_2_7_2_2 doi: 10.6004/jnccn.2008.0080 – ident: e_1_2_7_7_2 doi: 10.1002/lary.20638 – ident: e_1_2_7_8_2 doi: 10.1002/(SICI)1097-0347(199812)20:8<739::AID-HED13>3.0.CO;2-0 – ident: e_1_2_7_16_2 doi: 10.1200/JCO.2008.17.8905 – ident: e_1_2_7_6_2 doi: 10.1002/1097-0142(19930901)72:5<1756::AID-CNCR2820720540>3.0.CO;2-5 – ident: e_1_2_7_13_2 doi: 10.1097/MLG.0b013e31805d017b – ident: e_1_2_7_10_2 doi: 10.1002/cncr.22410 – ident: e_1_2_7_9_2 doi: 10.1002/hed.20734 – ident: e_1_2_7_5_2 doi: 10.1002/hed.20654 – ident: e_1_2_7_3_2 doi: 10.1016/S0167-8140(00)00172-9 – reference: 22638936 - Strahlenther Onkol. 2012 Jul;188(7):637-8 |
SSID | ssj0003642 |
Score | 2.3084054 |
Snippet | Background
Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis,... Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is... |
SourceID | proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 935 |
SubjectTerms | Adult Aged Aged, 80 and over Biological and medical sciences Carcinoma, Squamous Cell - diagnosis Carcinoma, Squamous Cell - secondary clinical utility Female head and neck imaging Head and Neck Neoplasms - diagnosis Head and Neck Neoplasms - pathology Head and Neck Neoplasms - secondary head and neck squamous cell carcinoma Humans Male Medical sciences Middle Aged Neoplasms, Unknown Primary - diagnosis Otorhinolaryngology (head neck, general aspects and miscellaneous) Otorhinolaryngology. Stomatology PET/CT Positron-Emission Tomography Predictive Value of Tests Preoperative Period Prospective Studies Squamous Cell Carcinoma of Head and Neck Tomography, X-Ray Computed Tumors unknown primary |
Title | Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial |
URI | https://api.istex.fr/ark:/67375/WNG-MGFFSN4R-V/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhed.21566 https://www.ncbi.nlm.nih.gov/pubmed/21674668 https://www.proquest.com/docview/872130385 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LixQxEA7LevHiA1_jYylExEvPozudTutpWWd2EHaQdVb3IIRKOs3KrBndmQHxL_inrerXMLKCeGs6FehUV5IvlaqvhHhBC56iBhkRtEV23YwijIs0GtpYqjgvdFwV7TuZqemZfHeenu-JN20uTM0P0TnceGZU6zVPcLSrwZY09MIX_ZhPH7T-cqwWA6LTLXVUomR90ykT9q_IllVoGA-6njt70Q1W6w-OjcQVqaes61pcBzx3cWy1EU1ui8_tEOr4k0V_s7Z99_MPdsf_HOMdcasBqHBYW9RdsefDPfGroQ-9BLJTBu6wLOH9eD44msOXAAQiYUsbzm20xBeAoYDg3QJW3zfILgbgawJwXL4oLL8isBOYpGAT2LUX4FtNffEaDulx2SaBQpu9CVWJkfvibDKeH02jpoxD5Ah8qai0vswSlIVCRwBIJl66XKU2zrJcKz1EjSOLQ3RMZGPJqKx0vhwVDi3hP6uTB2I_LIN_JED7VHptiwQR-cpW04s8L1A7Z0eZK3viVftDjWs4zrnUxqWp2ZljQxo1lUZ74nkn2ozuOqGXlVV0Eni14Ei4LDWfZsfm5Hgy-TCTp-ZjTxzsmE3XgRCQ5iycnoDWjgxNYFY3Bk-aN5rO4Anfz_bEw9q-tp05RUQpTcOqrOTvH2qm47fVw-N_F30ibtYOco49fir211cb_4wQ1toeVFPpN0OvIk0 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZKe4ALD_FaHmWEEOKyeex6HS_iUpWkAZoIlRR6qSzb6xUoxYE2kRB_gT_NjPcRBRUJcVutx9J6dmx_nvF8w9gzXPAENvAYoa0m100_1kmRxT2TcJHkhUxC0b7JVIyP-duT7GSLvWpyYSp-iNbhRjMjrNc0wckh3V2zhn52RSeh48cVtkMVvcOB6mhNHpUKXsU6eUoeFt7wCvWSbtt1YzfaIcX-oNuR-gIVVFaVLS6DnptINmxFoxvstBlEdQNl3lktTcf-_IPf8X9HeZNdrzEq7FVGdYttOX-b_aoZRM8ATZWwOyxKeD-cdfdn8MUD4khYM4dTG67yBWhfgHd2DhffV5q8DECRArBUwcgvvmogPzBKwcqTd8_Dt4r94iXs4eOiyQOFJoETQpWRO-x4NJztj-O6kkNsEX-JuDSuHKSaF0JbxEA8ddzmIjPJYJBLIXta6r7RPW2Jy8agXRluXdkvrDYIAY1M77Jtv_DuPgPpMu6kKVKtNUVtJb7I80JLa01_YMuIvWj-qLI1zTlV2zhTFUFzolCjKmg0Yk9b0Xp0lwk9D2bRSujzOV2GG2Tq0_RATQ5Gow9TfqQ-Rmx3w27aDgiCJCXiRAwaQ1I4h0nd2jvUvJJ4DE8pRBuxe5WBrTtTlogQEocVzOTvH6rGw9fh4cG_iz5hV8ezyaE6fDN995Bdq_zldBX5Edtenq_cYwRcS7Mb5tVvRVUmaA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGJiFeuIhbBgwLIcRL2jRxHAeeprVZuayaRgd7mGT5FoG6uWNrJcRf4E9zTm5V0ZAQb1FyLMUnn-0vxz7fIeQlTHgcHrAQqK3C0M0gVLFNw0jHjMe5FXFVtO9gwsfH7P1JerJB3ra5MLU-RBdww5FRzdc4wC9s2V-Jhn51thfj38cNssV4JBDSw6OVdlTCWb3VyRIMsLBWViiK-13TtcVoC_36Aw9HqivwT1kXtriOea4T2WolKu6Q07YP9QGUWW-50D3z8w95x__s5F1yu2GodLeG1D2y4fx98qvRDz2jAFRk7nRe0sPRtL83pd88BRZJV7rh-AzmeEuVt9Q7M6NX35cKYwwU9wmowfpFfn6uKEaBwYouPcb2PL2otS_e0F24nLdZoLRN36RVjZEH5LgYTffGYVPHITTAvnhYaldmiWKWKwMMiCWOmZynOs6yXHARKaEGWkXKoJKNBlRpZlw5sEZpIIBaJA_Jpp9795hQ4VLmhLaJUgr3bAXcyHOrhDF6kJkyIK_bDypNI3KOtTbOZC3PHEvwqKw8GpAXnWnTu-uMXlWo6CzU5QyPwmWp_DLZlwf7RfFpwo7k54DsrMGmawAUSGAaTkBoiyMJIxjdrbwDz0sBP-EJbtAG5FGNr1VjzBHhXEC3KpT8_UXleDSsLrb_3fQ5uXk4LOTHd5MPT8itOliO55Cfks3F5dI9A7a10DvVqPoN3GMlIA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+utility+of+PET%2FCT+in+the+evaluation+of+head+and+neck+squamous+cell+carcinoma+with+an+unknown+primary%3A+a+prospective+clinical+trial&rft.jtitle=Head+%26+neck&rft.au=Rudmik%2C+Luke&rft.au=Lau%2C+Harold+Y&rft.au=Matthews%2C+T+Wayne&rft.au=Bosch%2C+J+Douglas&rft.date=2011-07-01&rft.eissn=1097-0347&rft.volume=33&rft.issue=7&rft.spage=935&rft_id=info:doi/10.1002%2Fhed.21566&rft_id=info%3Apmid%2F21674668&rft.externalDocID=21674668 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-3074&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-3074&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-3074&client=summon |